Medicine and Dentistry
Absence
5%
Accuracy
5%
Activated Protein C
11%
Activated Protein C Resistance
50%
Adaptation
7%
Antithrombin
5%
Apixaban
50%
Assay
77%
Assessment
100%
Betrixaban
94%
Blood Clotting Factor 10a Inhibitor
70%
Blood Sampling
5%
Buffer
14%
Chemical Compound
5%
Coagulation
16%
Combination Therapy
14%
Dabigatran
11%
Diagnostic Error
5%
Diagnostic Test
44%
Direct Oral Anticoagulant
44%
Donor
7%
Edoxaban
5%
Emergency
5%
Fondaparinux
14%
Gestagen
5%
Heparin
22%
Inpatient
18%
Interference
16%
Laboratory
44%
Liquid Chromatography
5%
Liquid Chromatography-Mass Spectrometry
11%
Low Molecular Weight Heparin
48%
Lupus Anticoagulant
5%
Man
5%
Measurement
11%
Oral Contraceptive Agent
16%
Partial Thromboplastin Time
8%
Patient
16%
Plasma
100%
Protein C
5%
Protein C
5%
Protein S
11%
Prothrombinase
11%
Rivaroxaban
11%
Tandem Mass Spectrometry
11%
Therapeutic Procedure
5%
Thrombophilia
44%
Viper Venom
8%
Volunteer
5%
Woman
27%
Pharmacology, Toxicology and Pharmaceutical Science
Active Metabolite
44%
Anticoagulant Agent
12%
Apixaban
48%
Betrixaban
88%
Blood Clotting Factor 10a Inhibitor
79%
Buffer
14%
Clotting Time
19%
Dabigatran
8%
Daboia russellii
7%
Direct Oral Anticoagulant
57%
Edoxaban
48%
Emergency
50%
Fenfluramine
7%
Fibrinolytic Agent
12%
Fondaparinux
14%
Heparin
22%
Low Molecular Weight Heparin
48%
Prothrombin
47%
Rivaroxaban
10%
Thromboplastin
28%
Viper Venom
9%
Neuroscience
Blood Clotting Factor 10a
51%
Chromatography
48%
Edoxaban
88%
Fondaparinux
29%
Heparin
51%
Interference
14%
Low Molecular Weight Heparin
29%
Mass Spectrometry
48%